Drugs / maternal colostrum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02912585 | Jul 2013 → Jul 2016 | — | Federal University of Uberlandia | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | maternal colostrum | “assigned 113 VLBW infants to receive 0.2 mL of maternal colostrum or sterile water (placebo) via oropharyngeal route every 2 hours for 48 hours” PMID 30964820 ↗ Jul 2019 |
| Route | Other | “via oropharyngeal route” PMID 30964820 ↗ Jul 2019 |